Pamidronate decreases tumor‐induced osteoclastogenesis in osteopetrotic mice
- 1 July 2001
- journal article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 19 (4), 554-558
- https://doi.org/10.1016/s0736-0266(00)00065-6
Abstract
Recent studies indicate that the bisphosphonate pamidronate reduces skeletal complications caused by tumor osteolysis. In this investigation, the cellular mechanism through which pamidronate affects tumor-induced osteoclastogenesis is studied in osteopetrotic mice. A unique animal model is employed which studies the effect of pamidronate on a tumor (2472 sarcoma) which induces osteoclastogenesis in osteoclast-deficient mice (oplop). This model provides opportunity to specifically study effects on osteoclast formation and findings suggest that pamidronate decreases the number of osteoclasts at sites of 2472 tumor by decreasing the number of osteoclast precursor cells at the level of myeloid precursors. © 2001 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.Keywords
This publication has 14 references indexed in Scilit:
- Compactin Suppresses Bone Resorption by Inhibiting the Fusion of Prefusion Osteoclasts and Disrupting the Actin Ring in OsteoclastsJournal of Bone and Mineral Research, 2000
- Osteoclasts are required for bone tumors to grow and destroy boneJournal of Orthopaedic Research, 1998
- Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including RasJournal of Bone and Mineral Research, 1998
- Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.JCI Insight, 1997
- Osteoclast formation during tumor osteolysis does not require proliferating osteoclast precursor cellsJournal of Orthopaedic Research, 1997
- Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone MetastasesNew England Journal of Medicine, 1996
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996
- Tumor osteolysis in osteopetrotic miceJournal of Orthopaedic Research, 1995
- Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivoJournal of Bone and Mineral Research, 1995
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.JCI Insight, 1991